NCT05882370 2024-10-16TIPS Plus Cadonilimab in Advanced HCC with Tumor Thrombosis-associated Portal Hypertension:a Prospective, Single-arm, Phase II StudySun Yat-sen UniversityPhase 2 Recruiting30 enrolled